News and Announcements
Bioactive Laboratories Pty Ltd – CEO Interview
- Published June 25, 2014 3:34PM UTC
- Publisher Wholesale Investor
- Categories CEO Interviews
Bioactive Laboratories specialises in plant based solutions for human health.
They have developed the first anti-inflammatory and pain relieving agent that is gentle to the stomach. Studies show it rivals the drug efficacy and strength of NSAIDs such as Voltaren, without digestive side effects.
Global market sectors worth an estimated $560Billion annually make anti-inflammatories & pain agents the most widely used of all drugs and complementary medicines.
A faster route to market exists, than traditional biotech via the booming Complementary Medicine market to supply bulk powders & extracts.
Profitability within four years is predicted via a conservative financial model. This hybrid complementary medicine/drug development business model, suggests self funding for the development pipeline that includes drug candidates & revolutionary plant based solutions for type-2 diabetes.
Customers such as pharmaceutical & complementary medicine companies have been approached and are anxious to gain access.
To hear the latest on Bioactive Laboratories straight from the source, please listen to Rick Ferdinands, Founder & MD.
CEO Interviews
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
